Bachem Patents – Key Insights and Stats

Bachem has a total of 47 patents globally, out of which 19 have been granted. Of these 47 patents, more than 58% patents are active. The USA is where Bachem has filed the maximum number of patents, followed by Europe (EPO) and Israel. Parallelly, Europe (EPO) seems to be the main focused R&D center of Bachem.

Bachem was founded in the year 1971. Company is a Swiss bio-technology company active in the fields of chemistry, biochemistry and pharmaceuticals.

Do read about some of the most popular patents of Bachem which have been covered by us in this article and also you can find Bachem patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Bachem patent portfolio.

How many patents does the CEO of Bachem have?

The CEO, Thomas Meier, has 0 patents.

How many patents does Bachem have?

Bachem has a total of 47 patents globally. These patents belong to 17 unique patent families. Out of 47 patents, 30 patents are active.

How Many Patents did Bachem File Every Year?

Bachem Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantBachem Applications FiledBachem Patents Granted
202233
20214
202051
20193
20183
2017172
20163
201511
2014
201312
20121
201111

How many Bachem patents are Alive/Dead?

Worldwide Patents

Bachem Patent Portfolio

How Many Patents did Bachem File in Different Countries?

Bachem Worldwide Patent Filing

Where are Research Centers of Bachem Patents Located?

R&D Centres of Bachem

10 Best Bachem Patents

US8080523B2 is the most popular patent in the Bachem portfolio. It has received 21 citations so far.

Below is the list of 10 most cited patents of Bachem:

Publication NumberCitation Count
US8080523B221
WO2019120639A115
EP1864973A112
EP1466884A111
US8440621B210
CN109311960A10
US11377276B24
US9061071B22
US8569452B22
WO2020212477A12

List of Bachem Patents

Bachem PatentsTitle
US20220213139A1Manufacture Of Disulfide Bonded Peptides
US11377276B2Drying Container
US11186608B2Solid Phase Synthesis Of Acylated Peptides
US11117946B2Method For Preparing Glucagon-Like Peptides
US20210122782A1Manufacture Of Glucagon Peptides
US20200371069A1Purification Of Glucagon-Like Peptide 1 Analogs
US10690635B2Purification Of Glucagon-Like Peptide 1 Analogs
US20170274047A1Analogs Of Shk Toxin And Their Uses In Selective Inhibition Of Kv1. 3 Potassium Channels
US9616102B2Analogs Of Shk Toxin And Their Uses In Selective Inhibition Of Kv1.3 Potassium Channels
US9061071B2Analogs Of Shk Toxin And Their Uses In Selective Inhibition Of Kv1.3 Potassium Channels
US8569452B2Preparation Of Phalloidin And Its Derivatives
US8440621B2Analogs Of Shk Toxin And Their Uses In Selective Inhibition Of Kv1.3 Potassium Channels
US8080523B2Analogs Of Shk Toxin And Their Uses In Selective Inhibition Of Kv1.3 Potassium Channels
EP4161942A1Improved Oligonucleotide Synthesis
EP3433267B1Method For Preparing Glucagon-Like Peptides
EP3956343A1Manufacture Of Disulfide Bonded Peptides
EP3433268B1Purification Of Glucagon-Like Peptide 1 Analogs
EP3728304A1Solid Phase Synthesis Of Acylated Peptides
EP2474316B1Analogs Of Shk Toxin And Their Uses In Selective Inhibition Of Kv1.3 Potassium Channels
EP1724260B1Process For The Synthesis Of (2S, 3Ar, 7As)Octahydroindole-2-Carboxylic Acid And Its Conversion To Trandolapril
EP1864973A1Process For The Preparation Of Perindopril And Salts Thereof
EP1466884A1Process For The Preparation Of Resveratrol And Its Uses
CN109641946AMethod For Preparing Glucagon-Like Peptides
CN109311960APurification Of Glucagon-Like Peptide 1 Analogs
WO2022214692A1Pseudo Solid Phase Protecting Group And Methods For The Synthesis Of Oligonucleotides And Oligonucleotide Conjugates
WO2022195111A1Improved Oligonucleotide Synthesis
WO2020212477A1Manufacture Of Disulfide Bonded Peptides
WO2019149723A1Manufacture Of Glucagon Peptides
WO2019120639A1Solid Phase Synthesis Of Acylated Peptides
WO2017137637A3Drying Container
WO2017162650A1Method For Preparing Glucagon-Like Peptides
WO2017162653A1Purification Of Glucagon-Like Peptide 1 Analogs
CA3018618A1Method For Preparing Glucagon-Like Peptides
CA3018627A1Purification Of Glucagon-Like Peptide 1 Analogs
CA2582149CAnalogs Of Shk Toxin And Their Uses In Selective Inhibition Of Kv1.3 Potassium Channels
DE602017060962T2Process For Production Of Glucagon-Like Peptides
IL287199AManufacture Of Disulfide Bonded Peptides
DE602017042857T2Purification Of Glucagon-Like Peptide-1 Analogues
IL276067AManufacture Of Glucagon Peptides
IL261846APurification Of Glucagon-Like Peptide 1 Analogs
IL261845AMethod For Preparing Glucagon-Like Peptides
HK1173079A1Analogs Of Shk Toxin And Their Uses In Selective Inhibition Of Kv1.3 Potassium Channels
ES2580233T3Analogs Of Shk Toxin And Their Uses In Selective Inhibition Of Kv1.3 Potassium Channels
DE602005048922T2Analogs Of Shk Toxin And Their Use In The Selective Inhibition Of Kv1.3 Potassium Channels
DE602005004897D1Process For The Preparation Of I(2S,3Ar,7As)-Octahydroindole-2-Carboxylic Acid And Conversion To Trandolapril
AT386718TProcess For Production Of (2S, 3Ar, 7As)- Octahydroindole-2-Carbonic Acid And Conversion To Trandolapril
GB0504857D0Novel Compounds And Their Effects On Feeding Behaviour

What are Bachem’s key innovation segments?

What Technologies are Covered by Bachem?

The chart below distributes patents filed by Bachem in different countries on the basis of the technology protected in patents. It also represents the markets where Bachem thinks it’s important to protect particular technology inventions.

R&D Focus: How has Bachem‘s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Bachem?

Table of Content

Insights you may find interesting

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.